Insmed, Inc. (INSM)
107.09
-2.05
(-1.88%)
USD |
NASDAQ |
May 18, 16:00
107.09
0.00 (0.00%)
After-Hours: 20:00
Insmed Research and Development Expense (Quarterly) : 209.48M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Madrigal Pharmaceuticals, Inc. | 108.31M |
| ACADIA Pharmaceuticals, Inc. | 76.87M |
| PTC Therapeutics, Inc. | 100.87M |
| Revolution Medicines, Inc. | 341.62M |
| United Therapeutics Corp. | 138.20M |